Ashutosh Lal is an Oncology physician affiliated with University of California, San Francisco. OpenAlex indexes 139 publications with 2,364 citations (h-index 25); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Hematology/oncology, Children'S Hospital
747 52nd St
Oakland, CA 946091809
Telephone
510-428-3172Registry record last updated 16 Aug 2010.
Clinical trials
- Carbon Monoxide Measurement to Screen for Sickle Cell Disease
Sponsor: UCSF Benioff Children's Hospital Oakland
- Impact of a Nutritional Supplement on Metabolic Health
Sponsor: UCSF Benioff Children's Hospital Oakland
- Effect of Blueberry Consumption on Metabolic Syndrome & DNA Damage
Sponsor: UCSF Benioff Children's Hospital Oakland
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genetix Biotherapeutics IncProgram year20251 payment
- E.R. Squibb & Sons, L.L.C.Program year20241 payment
- Vertex Pharmaceuticals IncorporatedProgram year20239 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Other
100%Iron Chelator100%Ferriprox (2 Times A Day)100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2004–2005 per NIH RePORTER. The latest:
- BONE MINERAL DENSITY IN CHILDREN WITH SICKLE CELL ANEMIA
University of California San Francisco
FY2005$2,991M01RR001271 - Bone Mineral Density in Children with Sickle Cell Anemia
University of California San Francisco
FY2004$38,579M01RR001271
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”